2024 HCPCS Code J7633
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
TAGS: final inhalation through milligram administered concentrated
| Short Description | Budesonide non-comp con |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Code Added Date | January 01, 2003 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J3302 - Triamcinolone diacetate inj
- J3303 - Triamcinolone hexacetonl inj
- J3304 - Inj triamcinolone ace xr 1mg
- J3305 - Inj trimetrexate glucoronate
- J3310 - Perphenazine injeciton
- J3315 - Triptorelin pamoate
- J3316 - Inj., triptorelin xr 3.75 mg
- J3320 - Spectinomycn di-hcl inj
- J3350 - Urea injection
- J3355 - Urofollitropin, 75 iu
- J3357 - Ustekinumab sub cu inj, 1 mg
- J3358 - Ustekinumab, iv inject, 1 mg
- J3360 - Diazepam injection
- J3364 - Urokinase 5000 iu injection
- J3365 - Urokinase 250,000 iu inj
- J3370 - Vancomycin hcl injection
- J3371 - Inj, vancomycin hcl (mylan)
- J3372 - Inj, vancomycin hcl (xellia)
- J3380 - Inj vedolizumab iv 1 mg
- J3385 - Velaglucerase alfa